THE 2026 COMMERCIAL REALITY
Innovation is Table Stakes.
Market Dominance is Architected.
Stop marketing to clinicians. Start solving for the actuary. I build the commercial engines that translate clinical potential into audit-survivable revenue.
National Ecosystem Reach
Architecting commercial pathways for clients operating across the Top 10 National Payers, Providers, and Biopharma companies. We align innovation with the economic requirements of portfolios covering over 100M+ total lives.
High-Growth Deployment
Designed the go-to-market architecture to activate 1M+ eligible lives for emerging medical technology, converting clinical potential into a scalable commercial footprint and high-value payer contracts.
Multi-Channel Architecture
Navigating the intersection of early-stage innovation and enterprise-scale health systems. We design the contracting logic and commercial pathways that allow startups and growth-stage companies to successfully integrate with National Payers, Providers, and the Top 10 Global Biopharma ecosystem.
Partnership Approach
Who We Partner With
Founders & CEOs advancing from validated outcomes to scalable health system adoption.
Commercial & Market Access Leaders driving payer, provider, and employer traction.
Venture & Private Equity Firms aligning commercialization strategy to portfolio value creation.
How We Partner
We design and run the commercialization system — aligning payers, providers, and employers around a shared economic value model and leading the revenue engine that scales adoption and enterprise value.
Engagement Model
Commercial Architecture Sprint (60–90 Days)
Clarify value logic, design market pathways, and build the commercialization blueprint.
Commercial Engine Leadership (6–18 Months)
Axis embeds as the commercialization function, operating the revenue engine and scaling adoption.
The Axis Perspective
Axis was founded to solve the gap between validated clinical outcomes and the economic clarity required for real adoption. Healthtech companies often have strong science, compelling outcomes, and great intent — but struggle to turn that proof into payer, provider, and employer decisions that scale.
Tom Riley built Axis after seeing this gap across behavioral health, neuropharmacology research, and leadership roles at Genentech, Kaiser Permanente, Deloitte, and CVS Health/Aetna. The lesson was consistent: outcomes alone don’t drive contracts or growth. Economic clarity does.
Axis exists to provide that clarity.
We design and operate commercialization systems that translate clinical insight into economic value — and build the commercial engine required for adoption, contracting expansion, and sustained revenue growth.
This is not advisory.
This is embedded commercialization leadership built to accelerate scale.
Architect the Next Stage of Commercialization
Axis Growth Partners works with commercialization leaders advancing validated outcomes into scalable adoption. We identify the structural friction inside the growth model, then design the operating architecture, pathways, contracting logic, and commercial rhythms that remove it.
If you’re clarifying your commercialization model or preparing to scale adoption across payer, provider, and employer channels, we should align.
